Navigation Links
Prime Therapeutics Introduces Efficiency Program to Help Employers Understand How to Most Effectively Spend Pharmacy Dollars
Date:2/26/2008

ST. PAUL, Minn., Feb. 26 /PRNewswire/ -- Prime Therapeutics (Prime), a thought leader in pharmacy benefit management, announced today the release of its Efficiency Program. The Efficiency Program provides a targeted approach to value-based pharmacy management and helps employers understand how to spend their limited health care dollars in ways that are most beneficial to the health of their employees. Prime will be presenting this new program at the Pharmacy Benefit Management Institute (PBMI) 2008 Drug Benefit Conference on February 28, 2008.

Prime's Efficiency Program was developed as a tool to help plan sponsors control health care costs while improving the health of their members. The program focuses on core therapeutic categories where evidence-based medicine demonstrates a proven positive health outcome. For each core therapeutic category, Prime uses predictive modeling logic and medical claims information to identify members at high risk for an adverse health event within a population. Pharmacy claims are then used to determine which members have been prescribed a drug therapy and which members have not. Prime's Efficiency Program combines both pieces of information to provide a metric that plan sponsors can use to gauge how efficiently they are spending their pharmacy benefit dollars.

Patrick Gleason, PharmD, Prime's Director of Clinical Outcome Assessment, indicates, "This approach focuses on overall health care including both medical and pharmacy care. This program will help plan sponsors answer the question: are we spending our pharmacy dollars effectively and where do we need to make improvements?"

Gleason will be presenting the Efficiency Program and will provide tangible examples of the value of integrating medical and pharmacy claims to improve pharmacy benefit performance at the 2008 PBMI Drug Benefit Conference in Phoenix, Arizona, on February 28, 2008.

Using the information provided through Prime's Efficiency Program, clients may choose to implement clinical programs or value-based benefit designs, or a combination of the two. Prime offers clinical programs that implement different member interventions based on whether members are at high risk for an adverse health outcome. Value-based benefit designs provide plan sponsors with the opportunity to remove cost barriers for impacted members. This type of design often includes offering generic drugs in a particular therapeutic category at a lower cost.

As part of its commitment to supporting clients in the development of innovative pharmacy benefits, Prime was the first pharmacy benefit manager to join the Center for Health Value Innovation, a non-profit organization that collaborates with leading organizations to develop and promote value-based health strategies with the end goal of improving the health of employees.

Prime Therapeutics is a pharmacy benefit management company dedicated to providing innovative, clinically based, cost-effective pharmacy solutions for clients and members. Providing pharmacy benefit services nationwide to approximately 14.6 million covered lives, its client base includes Blue Cross and Blue Shield Plans, employer and union groups, and thirdparty administrators. Headquartered in St. Paul, Minnesota, Prime Therapeutics is collectively owned by 10 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans. Learn more at http://www.primetherapeutics.com.


'/>"/>
SOURCE Prime Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Prime Your Immune System During the Peak of Cold Season and Beyond
2. PrimeWest Health Chooses Healthations AboveHealth as Next Generation Provider Portal
3. Prime Therapeutics Becomes First PBM to Join the Center for Health Value Innovation
4. Health Capital Group Warns of Fallout to Hospitals From the Subprime Mortgage Crisis and Urges Hospitals to Immediately Reassess Existing Debt Structures and Capital Financing Plans
5. MDS Issues MDS US GAAP Primer
6. Fetal Alcohol Exposure May Prime Offspring for Alcoholism
7. Safety Concerns Prompt Prime to Remove Avandia(R) from Formulary
8. Announcing Prime Vendor Contract with LIHPA
9. Activist Groups Plea to Indian Prime Minister: Rollout Second-Line AIDS Treatment!
10. Prime Healthcare Services Acquires Centinela Hospital Medical Center
11. GenPrime Initiates External Clinical Trials of its Bacterial Contamination Test for Rapid Detection of Bacteria in Platelets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Pixel Film ... Pro X. , "Film editors can give their videos a whole new perspective by ... Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/25/2016)... ... , ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter ... bar too high can result in disappointment, perhaps even self-loathing. However, those who set ... , Research from PsychTests.com reveals that behind the tendency to set low ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: